Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 6INDUSTRY 4NIH 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 3Sarcoma 1Lymphoid 1Dermatologic 1

Conditions

Sarcoma 108Central Nervous System Neoplasms 42Osteosarcoma 38Gliosarcoma 34Glioblastoma 34Rhabdomyosarcoma 27Lymphoma 22Fibrosarcoma 22Liposarcoma 21Leiomyosarcoma 20Neuroblastoma 19Hemangiosarcoma 19Astrocytoma 19Sarcoma, Synovial 18Neuroectodermal Tumors, Primitive, Peripheral 18Dendritic Cell Sarcoma, Interdigitating 18Precursor Cell Lymphoblastic Leukemia-Lymphoma 17Neurofibrosarcoma 17Histiocytoma, Malignant Fibrous 17Brain Neoplasms 17Sarcoma, Kaposi 16Malignant mesenchymal tumor 16Burkitt Lymphoma 16Ovarian Neoplasms 15Recurrence 14Leukemia 14Sarcoma, Alveolar Soft Part 12Oligodendroglioma 12AIDS-related Kaposi sarcoma 12Hemangiopericytoma, Malignant 11

Interventions

imetelstat 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Neoplasms, Neuroepithelial × Sarcoma × Clear all
NCT01273090 2014-01-30

Imetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or Lymphoma

Children's Oncology Group

Phase 1 Completed
34 enrolled
CNSDermatologicLymphoidSarcoma

Astrocytoma, Burkitt Lymphoma, Glioblastoma, Hodgkin Disease, Immunoblastic Lymphadenopathy, Lymphoma, Lymphoproliferative Disorders, Mycosis Fungoides, Oligodendroglioma, Recurrence, Sezary Syndrome, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral, Central Nervous System Neoplasms, Lymphoma, Large-Cell, Anaplastic, Neoplasms, Neuroepithelial, Optic Nerve Glioma, Lymphoma, Extranodal NK-T-Cell, Dendritic Cell Sarcoma, Interdigitating, Intraocular Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡